MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B.

CONCLUSION: MiR-338-3p enhances the sensitivity of ovarian cancer cells to cisplatin by downregulating WNT2B. PMID: 31769245 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31769245?dopt=Abstract

Source: Yonsei Medical Journal - November 28, 2019 Category: Universities & Medical Training Authors: Niu Q, Liu Z, Gao J, Wang Q Tags: Yonsei Med J Source Type: research